Europlasma S.A. (1EZ0.F) is experiencing severe selling pressure in pre-market trading on April 22, 2026. The waste management company’s stock has plummeted 15% to €0.0136 per share on the XETRA exchange in Germany. This sharp decline reflects broader concerns about the company’s financial health and operational performance. Europlasma, which specializes in plasma torch systems for hazardous waste treatment and decarbonization solutions, faces mounting challenges. The stock has lost nearly all its value over the past year, down 99.96% annually. Investors are reassessing their positions as the company struggles with negative earnings and deteriorating fundamentals.
1EZ0.F Stock Price Action and Market Sentiment
The 1EZ0.F stock opened at €0.0164 before sliding to €0.0136, marking a 15% loss in early trading. Volume remains extremely thin at just 1 share traded against an average of 41,929 shares daily. This liquidity crisis signals investor abandonment of the security. The stock’s 52-week range tells a devastating story: it peaked at €56.00 but now trades near its €0.012 low. Track 1EZ0.F on Meyka for real-time updates on this distressed security.
The company’s market capitalization has eroded to just €25.05 million from much higher levels. Technical indicators show severe weakness, with the RSI at 42.15 suggesting oversold conditions. However, the ADX reading of 31.65 indicates a strong downtrend remains firmly in place. The Williams %R at -96.28 confirms extreme selling pressure with virtually no buying interest.
Financial Deterioration and Negative Earnings
Europlasma’s financial metrics paint a bleak picture for 1EZ0.F investors. The company reported a negative EPS of -€88.61, meaning it loses money on every share outstanding. Net income per share stands at -€160.20 trailing twelve months, indicating massive operating losses. Free cash flow per share is deeply negative at -€95.63, showing the company burns cash rapidly.
The operating profit margin sits at -47.22%, meaning the company loses nearly half of every euro in revenue. Net profit margin of -74.38% reveals the company cannot generate profits at any level. With 1.84 billion shares outstanding, dilution remains a critical concern for existing shareholders. These metrics explain why the stock has become virtually worthless.
Meyka AI Rating and Analyst Consensus
Meyka AI rates 1EZ0.F with a grade of B and a recommendation to HOLD, though this rating masks serious underlying problems. The grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. However, the company rating shows a concerning “Sell” recommendation with a rating score of just 2 out of 10.
The detailed breakdown reveals strong sell signals across multiple metrics. The DCF score of 1 with a “Strong Sell” recommendation indicates the company’s intrinsic value is near zero. ROA and PE ratios both score 1 with “Strong Sell” ratings. Only the ROE score of 5 suggests any positive aspect. These grades are not guaranteed and we are not financial advisors.
Waste Management Sector Context
Europlasma operates in the Industrials sector, specifically waste management. The broader Industrials sector on XETRA shows average performance with a PE ratio of 29.82 and net margin of 53.29%. However, 1EZ0.F trades at a massive discount to sector peers, reflecting its distressed status. The company’s price-to-sales ratio of 0.00065 is extraordinarily low, indicating the market assigns minimal value to its revenue generation.
The sector average debt-to-equity ratio stands at 0.93, but Europlasma’s negative equity makes traditional leverage metrics meaningless. The company’s current ratio of 0.80 falls below the sector average of 1.96, indicating potential liquidity stress. Working capital is deeply negative at -€13.48 million, suggesting operational challenges.
Market Sentiment: Trading Activity and Liquidation Pressure
Trading activity in 1EZ0.F remains virtually nonexistent, with only 1 share changing hands in pre-market trading. The average daily volume of 41,929 shares appears inflated by occasional block trades or forced liquidations. The Money Flow Index reading of 87.53 indicates overbought conditions, yet prices continue falling, suggesting capitulation selling.
Liquidation pressure appears relentless as shareholders exit positions at any price. The stock’s year-to-date decline of 93.44% and five-year loss of 100% indicate complete shareholder destruction. The relative volume metric of 0.0000238 shows trading is essentially frozen. This environment creates a dangerous situation where any remaining holders face potential total loss with no exit liquidity.
Operational Challenges and Future Outlook
Europlasma S.A., based in Pessac, France, employs 1,870 people but generates insufficient revenue to support operations profitably. The company’s plasma torch technology addresses real market needs in hazardous waste treatment and decarbonization. However, execution failures and market adoption challenges have prevented commercial success. CEO Jerome Garnache-Creuillot faces an uphill battle to stabilize operations.
The company’s earnings announcement occurred on May 21, 2024, but results failed to inspire confidence. Revenue per share of €215.38 appears substantial, yet the company loses money on every transaction. This suggests pricing power issues or unsustainable cost structures. Without significant operational turnaround or capital injection, 1EZ0.F faces continued deterioration.
Final Thoughts
Europlasma S.A. (1EZ0.F) represents a cautionary tale of shareholder value destruction. The 15% pre-market decline on April 22 reflects ongoing market recognition that the company faces existential challenges. With negative earnings, deteriorating cash flow, and minimal trading liquidity, the stock has become increasingly difficult to value or exit. The company’s innovative plasma technology cannot offset fundamental business model failures. Meyka AI’s analysis platform tracks this distressed security, but the outlook remains deeply concerning. Investors holding 1EZ0.F should carefully reassess their positions given the severe financial deterioration and lack of near-term catalysts for recovery. The waste management sector offers healthier alternatives with proven profitability and positive cash generation. This stock exemplifies why thorough fundamental analysis matters before committing capital.
FAQs
The decline reflects shareholder concerns about Europlasma’s negative earnings, deteriorating cash flow, and weak fundamentals. The company operates at a loss despite generating revenue, signaling serious business model challenges.
1EZ0.F trades at €0.0136 per share on XETRA. The stock opened at €0.0164 before declining 15% in pre-market trading on April 22, 2026.
No. Europlasma reports negative earnings per share of -€88.61 and a net profit margin of -74.38%. Free cash flow per share is -€95.63, indicating severe operational losses.
Europlasma develops plasma torch systems for industrial applications in France, offering solutions for hazardous waste treatment, gas waste management, and decarbonization through solid recovered fuel transformation.
Meyka AI rates 1EZ0.F as “Sell” with a 2/10 score. The company faces severe financial challenges, negative cash flow, and minimal liquidity. Consult a financial advisor before investing.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)